Andere talen Deciphera Pharmaceuticals, Inc.

Aandelen

DCPH

US24344T1016

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,59 ^USD	+0,08%		0,00%	+58,65%

11/06	Deciphera Pharmaceuticals, Inc. kondigt wijzigingen aan in de raad van bestuur en comités	CI
03/06	Deciphera Pharmaceuticals kondigt mondelinge presentatie aan van de resultaten van de Motion Pivotal Fase 3-studie van vimseltinib bij patiënten met Tenosynovial Giant Cell Tumor (Tgct) tijdens de 2024 Asco Annual Meeting en online publicatie in de Lancet	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Ono Pharmaceutical Closes Deciphera Deal for About $2.4 Billion	11/06
Deciphera Pharmaceuticals, Inc. Announces Board and Committee Changes	11/06
Deciphera Pharmaceuticals Acquired by Ono Pharmaceutical for $2.4 Billion	11/06
Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) dropped from NASDAQ Composite Index	11/06
Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) dropped from S&P Global BMI Index	11/06
Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) dropped from S&P TMI Index	11/06
Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) dropped from S&P Biotechnology Select Industry Index	11/06
Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) dropped from NASDAQ Biotechnology Index	10/06
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet	03/06
Deciphera Pharmaceuticals Announces Oral Presentation of Results from Motion Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor At the 2024 Asco Annual Meeting and Online Publication in the Lancet	03/06
Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH	02/05
North American Morning Briefing : Traders Wait for -2-	01/05
North American Morning Briefing : More Earnings -2-	30/04
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	30/04
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH	29/04
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	29/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	29/04
Top Midday Gainers	29/04
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	29/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Deciphera Pharmaceuticals, Inc.

Aandelen

DCPH

US24344T1016

Andere talen

Filters